SGMO Sangamo Therapeutics Inc

$SGMO and I are working everyday, along with all other equity committee members, to create value and do best by equity and for equity. Info will be released publicly at the appropriate time and hopefully sooner rather than later. This has been a tremendous obligation on our time for which we are being paid nothing. Best regards all.

$SGMO I just posted my updated Equity Waterfall on X since we had the Claims Register filing as of Oct 5, and the August MOR......

$SGMO Well folks, being stuck in the Expert Market absolutely sucks, but it doesn't change my equity waterfall analysis or my outlook on potential shareholder recovery. Personally, I hate being limited to selling only in such an unbalanced, illiquid market. The flexibility to buy additional shares on positive news or sell/trim a position when necessary has been severely compromised. Unfortunately, this is one of the risks of investing in a company navigating Chapter 11 bankruptcy. That said, the underlying assets, potential milestone payments, and remaining liabilities haven't suddenly changed because of this trading restriction. For me, the focus now shifts back to what really matters: the upcoming Chapter 11 reorganization plan, remaining asset sales, and ultimately what value can be preserved for existing shareholders. Frustrating? Absolutely. But my investment thesis remains unchanged.

$SGMO My post on X showing how valuable Sangamo France actually is to Sangamo equity holders. With a 4.7 mil euro payment due this month, they should have almost $10 mil, minus around 25-50k a month for OE, rough estimate as SF is just being kept open for tax purposes.....

$SGMO Okay, here are my current thoughts. The new plan sponsor is coming. The plan is expected to be released in October. The sponsor would need to bring in roughly 60–80 million—which is essentially the amount that should remain as pure cash. I also believe that no other company will be integrated into the shell, given that there is still a revolutionary program in the form of ST-503. I think a buyout could follow a relisting on the Nasdaq; it depends on what the ST-503 data shows.

$SGMO it must be chiselled in our minds that the current share price does not reflect at all the value of the estate in the Ch11 case. I had some margin calls Friday when the price dropped to $.06 so was forced to convert some £ to $... but I am still here with my 79k shares at $.21 I am good at waiting, I am very resilient, bt I'll see the end of this one! For many years I've traded Sangamo, made money lost money, it's the nature of this game.

$SGMO So, here is my summary based on the latest dockets. I anticipate that the Chapter 11 proceedings will result in a payout of approximately $0.30 to $0.35 per share. Furthermore, existing shareholders will receive new shares in "Sangamo 2.0"—this is because the plan sponsor cannot wipe out the original shareholders, as doing so would forfeit the value of the tax assets (tax attributes). In addition, existing shareholders will receive CVRs (Contingent Value Rights) equivalent to $0.24 per share. We are seeing the same playbook here that was used in the Hertz case.

$SGMO Just posted on Sangamo website: ST-520 is finally going to auction!!! In my mind, that pretty much confirms a sale with proceeds to be distributed, not a re-float. Expected to be completed in 4Q

$SGMO In fact, the intrinsic value has likely increased, given the pending auctions and the potential monetization of the public shell company. I also believe that the hemophilia program will find a buyer. Anyone selling now is beyond help. The "Expert Market" enforces the patience required until the payout occurs… In my view, Grekko’s "waterfall" calculations are actually on the conservative side…

$SGMO can't help but wonder if our fellow shareholders representing us on the committee have been sucked into the morass that is SGMO - would love to see some sort of timeline commitment - that we used to have - in terms of court dates - now - no idea when this is going to be put to bed and/or if there is SGMO - part 2 - which i wholeheartedly vote NO on - btw - please lets get this done - please put out next steps and a timeline - this is way overdue to be done - it's mid - october - this was supposed to be done early to mid - September

$SGMO RBC says $PTCT looking for more deals , also in #CNS so maybe $PTCT will also be a bidder for $SGMO NAV1.7 ....

$SGMO as if we didn’t know already, I think it’s abundantly clear that mgmt is actively trying to harm shareholders. Hope they get exposed and incur whatever wrath the justice system can impose on them.

$SGMO I know logically and risk mgmt wise I shouldn’t buy anymore because I’m already loaded up, but man oh man I’m really itching to buy more while it stays around .14. Just hard to imagine its worth any less than current price, and 2x upside looks soooo locked in. Even 3x isnt out of question. What to do? What to do?

$SGMO I calculate a cash position of 110 million by the end of August—roughly 0.26 dollars per share. Base is the MOR Report from August

$SGMO Just had a nice dream… We weren’t just paid out and sent home. The negotiations resulted in a cash payout, plus future milestone rights, plus shares in the new tax-shield entity. That’s exactly why the EC took its time—they were structuring the ultimate hybrid exit. And then, unfortunately, I woke up… but who knows?

$SGMO Updated waterfall using the latest filings through D539: Post-DIP cash: ~$120.8M Less remaining claims / fees / reserves: ~-$42.4M Residual cash: ~$78.4M = ~$0.19/share * ST-503 / Remaining Assets: ~$50M * Sangamo France: ~$15M * Fabry milestone PV: ~$42M * NOL / Plan Sponsor / other value: ~$15M * Warrants: ~-$4M Central recovery: ~$196M = ~$0.47-$0.48/share. Importantly, cure costs and a large portion of professional fees have already been paid/funded, so they should not be double-counted. And the upside is still open: Remaining Asset bids are due Nov. 13, auction Nov. 17 if competitive, and Plan Sponsor bids remain open through plan confirmation. $0.47-$0.48 is my current central case — not the ceiling.

$SGMO $SGMO on the "expert market now " ... Quotations in Expert Market securities are restricted from public viewing manipulation trades so far this morning 1 cent to .143 volume 100K only value still at least .25 .50 with Fabry approval date set for omnibus hearing december15

$SGMO per court documents now employed a french consultant to assist with the french operations.# 550

$SGMO There's a small loophole in possibly buying the stock.....but......it didn't work for me on Schwab. You can ask for the traders desk and see if they can put the trade through. Will cost more....don't know...maybe $100 or so, guessing. Schwab said that is a way of buying when the stock is in the expert market but they are still restricted re sgmoq. Oh well...

$SGMO may have a case on cancelling the shares issued to Sandy, the Board and employees right before moving ahead with liquidation!